je.st
news
Following side effect concerns, Ariad suspends sales of cancer drug Iclusig at FDA's...
2013-10-31 18:10:49| Biotech - Topix.net
Ariad Pharmaceuticals is suspending sales of its leukemia drug Iclusig because of concerns that patients could suffer from blood clots.
Tags: side
sales
effect
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||